Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs-Updated Review.
Honorata Mruk-MazurkiewiczMonika KulaszyńskaJakubczyk KarolinaKatarzyna JandaWiktoria CzarneckaEwa Rębacz-MaronSławomir ZachaJerzy SieńkoSamir ZeairBartosz DalewskiWojciech MarliczIgor ŁoniewskiKarolina Skonieczna-ŻydeckaPublished in: Biomedicines (2023)
As pharmacology and science progress, we discover new generations of medicines. This relationship is a response to the increasing demand for medicaments and is powered by progress in medicine and research about the respective entities. However, we have questions about the efficiency of pharmacotherapy in individual groups of patients. The effectiveness of therapy is controlled by many variables, such as genetic predisposition, age, sex and diet. Therefore, we must also pay attention to the microbiota, which fulfill a lot of functions in the human body. Drugs used in psychiatry, gastroenterology, diabetology and other fields of medicine have been demonstrated to possess much potential to change the composition and probably the function of the intestinal microbiota, which consequently creates long-term risks of developing chronic diseases. The article describes the amazing interactions between gut microbes and drugs currently used in healthcare.
Keyphrases
- healthcare
- end stage renal disease
- endothelial cells
- systematic review
- newly diagnosed
- chronic kidney disease
- human health
- ejection fraction
- randomized controlled trial
- peritoneal dialysis
- physical activity
- public health
- smoking cessation
- patient reported outcomes
- prognostic factors
- induced pluripotent stem cells
- copy number
- working memory
- cell therapy
- climate change
- social media
- replacement therapy